SMARCA4 and hepatocellular carcinoma: miR-296-5p directly targets brahma-related gene-1 (BRG1), which binds to the SALL4 promoter and enhances SALL4 transcription, thereby inhibiting the stemness potency of HCC cells (Shi et al. 2020).